hyperthyroidism
TRANSCRIPT
Hyperthyroidism
Etiology :-
• Diffuse toxic goiter (Graves disease )
• Mc Cune Albright syndrome• Toxic uninodular goiter (Plummer disease )• Hyper functioning thyroid Ca• Thyrotoxicosis factitia• Subacute thyroiditis
• Acute suppurative thyroiditis
Graves disease
• Incidence :- It occurs in 1: 5000 children.
Peak at 11 – 15 years.
F :M 5 :1
• Etiology :-
Infiltration of thyroid gland with
lymphocytes & plasma cells.
CD4/Th- predominate in dense lymphoid
aggrgate.
CD8/Ts - predominate in low dense area.
Etiology
Activated beta lymphocytes, infiltrating the thyroid is higher than in peripheral blood.
CD4/Th activated beta cells
Plasma cells
TRSAb / TRBAb
TSH receptor
cAmp
Etiology
Ophthalmopathy :- Ab against thyroid & eye muscle Ag
TSH receptor
Eye muscle & orbital fibroblast
Glycosaminoglycans
Cytotoxic effects
Clinical manifestations
Manifestations of hyperthyroidism :-
Symptoms – • Hyperactivity, irritability,
• Altered mood, insomnia• Heat intolerance, increased sweating• Palpitations• Fatigue, weakness• Dyspnea
• Weight loss with increased appetite
• Pruritus• Increased stool frequency• Thirst & polyuria• Amenorrhea, loss of libido
Clinical manifestations
Manifestations of hyperthyroidism :-
Signs-• Sinus tacycardia • Atrial fibrillation
• High output heart failure• Fine tremor, hyperkinesis• Hyperreflexia• Warm, moist skin• Pamer erythema, onycholysis
• Hair loss
• Muscle weakness & wasting• Chorea, periodic paralysis
Clinical manifestations
Manifestations of Graves disease :-
• Diffuse goiter
• Ophthalmopathy – • Dalrymples sign• Von Graefe’s sign• Enroth’s sign• Gifford’s sign
• Stellwag’s sign
Clinical manifestations
Manifestations of Graves disease :-
• Conjunctival sign• Pupillary sign• Ocular mobility defects
• Exophthalmos• Exposure keratitis• Optic neuropathy• Localised dermopathy• Lymphoid hyperplasia
• Thyroid acropachy
Diagnosis
Lab findings :-
Hyperthyroidism –
T3, T4, TG ed ; TSH ed
Increased TBG levels –
T4 ed, T3 N - ed,
FT4,TSH - N
Familial dysalbuminemic hyperthyroxinemia –
T4 ed, T3 N - ed,
FT3,FT4,TSH - N
Functional thyroid nodule –
T3 - ed,
Diagnosis
Thyroid hormone unresponsiveness –
T4, T3, FT4, FT3 ed ;
TSH N - ed
Pit unresponsiveness toThyroid hormone -
TSH N- ed
TSH secreting pit tumor –
TSH ed alfa chain
Exogenous T4 –
FT4 ed,
TSH ed, TG ed
Treatment
Drugs :-
1. Propylthiouracil - ( PTU )
• Dose to dose less potent.• Highly plasma protein bound.• Less transferred across placenta, milk• Plasma T ½ is 1- 2 hour• Single dose acts for 4-8 hour
• No active metabolite• Multiple doses• Inhibit peripheral T4 T3
Treatment
2. Carbimazole –
• 3 times more potent• Less bound to plasms proteins• Large amount transferred across placenta• Plasma T ½ is 6 – 8 hour• Acts for 12 - 24 hour
• Methimazole is active metabolite• Single dose• Does not inhibit peripheral T4 T3
Treatment
Dose :-
• Propylthiouracil - ( PTU )
5 - 10 mg/kg/day TDS orally• Methimazole –
0.25 – 1.0 mg/kg/day OD orally• Propranolol –
0.5 – 2 mg/kg/day TDS orally
Clinical response in 2–3 weeks
Adequate control in 1–3 months
Duration – 5 years
Treatment
• Subtotal thyroidectomy –
ATD is given for 2-3 mo to obtain euthyroid
state. 5 drops of saturated solution of KI
dailyfor 2 wk
• Radioiodine – Safe in more than 10 years age
Pretreatment with ATD not necessary
ATD should be stopped a week before
starting RI
Propranolol & low dose ATD for 2-3 mo
Side effects
ATD – Transient leukopenia
Transient urticarial rash
Hypersensitivity
Agranulocytosis
Hepatitis
Lupus like syndrome
Glomerulonephritis
vasculitis
Side effects
• Subtotal thyroidectomy – Paralysis of vocal cord
Hypoparathyroidism
• Radioiodine –
Benign adenoma ( 0.6-1.9 % )
Hypothyroidism ( 10-20 % )
Congenital hyperthyroidism
Etiology : –• Transplacental passage of TRSAb • 2 % of infants are born to mothers with
graves disease• M : F - 1 : 1
Clinical features : - • PT /IUGR with goiter
• Restless, irritable,• Hyperactive,anxious• Microcephaly with ventricular enlargement• Eyes widely open, exophthalmos
Congenital hyperthyroidism
• Tachycardia, • Tachypnea, • Hyperthermia• Weight loss despite revenous appetite
• Jaundice, • HSM• Cardiac decompensation, • HT• Advanced bone age,
• Frontal bossing with triangular facies,• Craniosynostosis
Treatment
Drugs :-
• Propranolol –
1 – 2 mg/kg/day TDS orally
• PTU –
5 – 10 mg/kg/day TDS orally
• Lugol solution –
1 drop every 8 hr
Digitalization
Most cases remit in 3–4 mo